Effect of Esketamine on Reducing Postoperative Anxiety and Depression in Adolescent Patients

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

October 10, 2023

Primary Completion Date

December 10, 2024

Study Completion Date

February 10, 2025

Conditions

Anxiety-depression

Interventions

DRUG

Esketamine

Group S received a subanesthetic dose of esketamine 0.2mg/kg (2ml/50 mg) 5 minutes before the procedure began.

All Listed Sponsors

lead

Henan Provincial People's Hospital

OTHER

NCT06073015 - Effect of Esketamine on Reducing Postoperative Anxiety and Depression in Adolescent Patients | Biotech Hunter | Biotech Hunter